Analysts have torn into AB Science over the clinical trial compliance failings identified by regulators in France.

The FDA has sent a warning letter to a trial site studying Ionis Pharmaceuticals’ IONIS-TTRrx.

As expected, Scott Gottlieb, M.D., has been confirmed as the new head of the FDA, about four months after his Obama-picked predecessor Robert Califf stepped…

Biotech billionaire Patrick Soon-Shiong has been through the media wringer in the last few months, so will welcome an FDA green light that will draw attention…

Biotech executives and the head of the NIH are set to meet with top White House officials today.

Small cap biotech Durect Corporation has signed a $20 million upfront deal, with biobucks down the line, with Novartis for the biotech’s troubled late-stage…

Regulus Therapeutics has axed 30% of its workforce to conserve cash for its stuttering pipeline.

Two months ago, Accera registered a late-stage flop for its much-derided “brain food” candidate AC-1204 in Alzheimer’s, but now the company is looking to…

Sunesis Pharmaceuticals has been forced to concede defeat in its bid to bring vosaroxin to the E.U. market for acute myeloid leukemia.

Regulatory